The Kpnb1 antibody is a research tool designed to detect and study the Karyopherin beta 1 (Kpnb1) protein, a critical nuclear transport receptor. Kpnb1 facilitates the import of proteins containing nuclear localization signals (NLS) into the nucleus, often in conjunction with importin alpha adaptors . The antibody is widely used in molecular biology for techniques such as Western blotting, immunoprecipitation, and immunofluorescence to analyze Kpnb1 expression and localization in diverse cell types .
Cancer progression: Overexpression of Kpnb1 correlates with poor prognosis in EOC and AML .
Therapeutic targeting: Importazole, a small-molecule inhibitor, inhibits Kpnb1 function, enhancing chemotherapy efficacy .
Proteostasis regulation: Kpnb1 maintains protein homeostasis; its inhibition disrupts nuclear import of cargoes like APC/C and HMGB2 .
Epitope specificity: The BAR-based antibody (residues 301-320) distinguishes cytoplasmic Kpnb1 from nuclear pools, enabling precise subcellular analysis .
Cross-reactivity: Antibodies from Abcam and Cell Signaling cross-react with human, mouse, and rat Kpnb1 (97%–99% sequence identity) .